Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2045732402', 'doi': 'https://doi.org/10.1081/cnv-120016408', 'title': 'Cancer Drug Development in Europe: A Selection of New Agents Under Development at the European Drug Development Network', 'display_name': 'Cancer Drug Development in Europe: A Selection of New Agents Under Development at the European Drug Development Network', 'publication_year': 2003, 'publication_date': '2003-01-01', 'ids': {'openalex': 'https://openalex.org/W2045732402', 'doi': 'https://doi.org/10.1081/cnv-120016408', 'mag': '2045732402', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/12643015'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1081/cnv-120016408', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S121125331', 'display_name': 'Cancer Investigation', 'issn_l': '0735-7907', 'issn': ['0735-7907', '1532-4192'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'review', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5081642866', 'display_name': 'Didier Lacombe', 'orcid': 'https://orcid.org/0000-0002-8956-2207'}, 'institutions': [{'id': 'https://openalex.org/I126419005', 'display_name': 'European Organisation for Research and Treatment of Cancer', 'ror': 'https://ror.org/04g9wby70', 'country_code': 'NL', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I126419005']}], 'countries': ['NL'], 'is_corresponding': False, 'raw_author_name': 'D. Lacombe', 'raw_affiliation_strings': ['European Organisation for Research and Treatment of Cancer, Assistant Director/New Drug Development Program, Avenue E. Mounier, 83-b11, 1200 Brussels, Belgium.'], 'affiliations': [{'raw_affiliation_string': 'European Organisation for Research and Treatment of Cancer, Assistant Director/New Drug Development Program, Avenue E. Mounier, 83-b11, 1200 Brussels, Belgium.', 'institution_ids': ['https://openalex.org/I126419005']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5042877348', 'display_name': 'A. Butler-Smith', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'A. Butler-Smith', 'raw_affiliation_strings': ['European Drug Development Network'], 'affiliations': [{'raw_affiliation_string': 'European Drug Development Network', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5109907671', 'display_name': 'P. Therasse', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I126419005', 'display_name': 'European Organisation for Research and Treatment of Cancer', 'ror': 'https://ror.org/04g9wby70', 'country_code': 'NL', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I126419005']}], 'countries': ['NL'], 'is_corresponding': False, 'raw_author_name': 'P. Therasse', 'raw_affiliation_strings': ['EORTC Data Center'], 'affiliations': [{'raw_affiliation_string': 'EORTC Data Center', 'institution_ids': ['https://openalex.org/I126419005']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5012804079', 'display_name': 'P. Fumoleau', 'orcid': 'https://orcid.org/0000-0002-2912-2170'}, 'institutions': [{'id': 'https://openalex.org/I126419005', 'display_name': 'European Organisation for Research and Treatment of Cancer', 'ror': 'https://ror.org/04g9wby70', 'country_code': 'NL', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I126419005']}], 'countries': ['NL'], 'is_corresponding': False, 'raw_author_name': 'P. Fumoleau', 'raw_affiliation_strings': ['EORTC Data Center'], 'affiliations': [{'raw_affiliation_string': 'EORTC Data Center', 'institution_ids': ['https://openalex.org/I126419005']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5064892508', 'display_name': 'S S Burtles', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2801316944', 'display_name': 'Cancer Research UK', 'ror': 'https://ror.org/054225q67', 'country_code': 'GB', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I2801316944']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'S. Burtles', 'raw_affiliation_strings': ['Cancer Research UK'], 'affiliations': [{'raw_affiliation_string': 'Cancer Research UK', 'institution_ids': ['https://openalex.org/I2801316944']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5047677453', 'display_name': 'Hilary Calvert', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2801316944', 'display_name': 'Cancer Research UK', 'ror': 'https://ror.org/054225q67', 'country_code': 'GB', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I2801316944']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'H. Calvert', 'raw_affiliation_strings': ['Cancer Research UK'], 'affiliations': [{'raw_affiliation_string': 'Cancer Research UK', 'institution_ids': ['https://openalex.org/I2801316944']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5080269874', 'display_name': 'Silvia Marsoni', 'orcid': 'https://orcid.org/0000-0002-5361-7122'}, 'institutions': [{'id': 'https://openalex.org/I4210151091', 'display_name': 'Candiolo Cancer Institute', 'ror': 'https://ror.org/04wadq306', 'country_code': 'IT', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210151091', 'https://openalex.org/I4210153126', 'https://openalex.org/I4210167100']}], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'S. Marsoni', 'raw_affiliation_strings': ['Istituto Oncologico Candiolo'], 'affiliations': [{'raw_affiliation_string': 'Istituto Oncologico Candiolo', 'institution_ids': ['https://openalex.org/I4210151091']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5086081284', 'display_name': 'Cristiana Sessa', 'orcid': 'https://orcid.org/0000-0001-8132-2527'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'C. Sessa', 'raw_affiliation_strings': ['S. Europe New Drug Organization'], 'affiliations': [{'raw_affiliation_string': 'S. Europe New Drug Organization', 'institution_ids': []}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5110112933', 'display_name': 'Jaap Verweij', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I126419005', 'display_name': 'European Organisation for Research and Treatment of Cancer', 'ror': 'https://ror.org/04g9wby70', 'country_code': 'NL', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I126419005']}], 'countries': ['NL'], 'is_corresponding': False, 'raw_author_name': 'J. Verweij', 'raw_affiliation_strings': ['EORTC Data Center'], 'affiliations': [{'raw_affiliation_string': 'EORTC Data Center', 'institution_ids': ['https://openalex.org/I126419005']}]}], 'institution_assertions': [], 'countries_distinct_count': 3, 'institutions_distinct_count': 3, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.078, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 5, 'citation_normalized_percentile': {'value': 0.137878, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 74, 'max': 76}, 'biblio': {'volume': '21', 'issue': '1', 'first_page': '137', 'last_page': '147'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11845', 'display_name': 'Cancer therapeutics and mechanisms', 'score': 0.992, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11845', 'display_name': 'Cancer therapeutics and mechanisms', 'score': 0.992, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10211', 'display_name': 'Computational Drug Discovery Methods', 'score': 0.976, 'subfield': {'id': 'https://openalex.org/subfields/1703', 'display_name': 'Computational Theory and Mathematics'}, 'field': {'id': 'https://openalex.org/fields/17', 'display_name': 'Computer Science'}, 'domain': {'id': 'https://openalex.org/domains/3', 'display_name': 'Physical Sciences'}}, {'id': 'https://openalex.org/T11016', 'display_name': 'Monoclonal and Polyclonal Antibodies Research', 'score': 0.9726, 'subfield': {'id': 'https://openalex.org/subfields/2741', 'display_name': 'Radiology, Nuclear Medicine and Imaging'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/drug-development', 'display_name': 'Drug Development', 'score': 0.8054317}, {'id': 'https://openalex.org/keywords/cancer-drugs', 'display_name': 'Cancer drugs', 'score': 0.6710105}], 'concepts': [{'id': 'https://openalex.org/C64903051', 'wikidata': 'https://www.wikidata.org/wiki/Q2198549', 'display_name': 'Drug development', 'level': 3, 'score': 0.8054317}, {'id': 'https://openalex.org/C2780035454', 'wikidata': 'https://www.wikidata.org/wiki/Q8386', 'display_name': 'Drug', 'level': 2, 'score': 0.69649863}, {'id': 'https://openalex.org/C3020340455', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Cancer drugs', 'level': 3, 'score': 0.6710105}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.5248237}, {'id': 'https://openalex.org/C81917197', 'wikidata': 'https://www.wikidata.org/wiki/Q628760', 'display_name': 'Selection (genetic algorithm)', 'level': 2, 'score': 0.49585065}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.43198407}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.31847462}, {'id': 'https://openalex.org/C41008148', 'wikidata': 'https://www.wikidata.org/wiki/Q21198', 'display_name': 'Computer science', 'level': 0, 'score': 0.2262598}, {'id': 'https://openalex.org/C154945302', 'wikidata': 'https://www.wikidata.org/wiki/Q11660', 'display_name': 'Artificial intelligence', 'level': 1, 'score': 0.0782164}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.07202092}], 'mesh': [{'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D015195', 'descriptor_name': 'Drug Design', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D007390', 'descriptor_name': 'International Agencies', 'qualifier_ui': 'Q000458', 'qualifier_name': 'organization & administration', 'is_major_topic': True}, {'descriptor_ui': 'D008495', 'descriptor_name': 'Medical Oncology', 'qualifier_ui': 'Q000458', 'qualifier_name': 'organization & administration', 'is_major_topic': True}, {'descriptor_ui': 'D012106', 'descriptor_name': 'Research', 'qualifier_ui': 'Q000458', 'qualifier_name': 'organization & administration', 'is_major_topic': True}, {'descriptor_ui': 'D020533', 'descriptor_name': 'Angiogenesis Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D020533', 'descriptor_name': 'Angiogenesis Inhibitors', 'qualifier_ui': 'Q000302', 'qualifier_name': 'isolation & purification', 'is_major_topic': False}, {'descriptor_ui': 'D020533', 'descriptor_name': 'Angiogenesis Inhibitors', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000911', 'descriptor_name': 'Antibodies, Monoclonal', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000911', 'descriptor_name': 'Antibodies, Monoclonal', 'qualifier_ui': 'Q000302', 'qualifier_name': 'isolation & purification', 'is_major_topic': False}, {'descriptor_ui': 'D000911', 'descriptor_name': 'Antibodies, Monoclonal', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000302', 'qualifier_name': 'isolation & purification', 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000145', 'qualifier_name': 'classification', 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D019496', 'descriptor_name': 'Cancer Vaccines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019496', 'descriptor_name': 'Cancer Vaccines', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D002986', 'descriptor_name': 'Clinical Trials as Topic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004260', 'descriptor_name': 'DNA Repair', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004260', 'descriptor_name': 'DNA Repair', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D004341', 'descriptor_name': 'Drug Evaluation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019008', 'descriptor_name': 'Drug Resistance, Neoplasm', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004354', 'descriptor_name': 'Drug Screening Assays, Antitumor', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004791', 'descriptor_name': 'Enzyme Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004791', 'descriptor_name': 'Enzyme Inhibitors', 'qualifier_ui': 'Q000302', 'qualifier_name': 'isolation & purification', 'is_major_topic': False}, {'descriptor_ui': 'D004791', 'descriptor_name': 'Enzyme Inhibitors', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D005060', 'descriptor_name': 'Europe', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007390', 'descriptor_name': 'International Agencies', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008495', 'descriptor_name': 'Medical Oncology', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009363', 'descriptor_name': 'Neoplasm Proteins', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D009363', 'descriptor_name': 'Neoplasm Proteins', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012106', 'descriptor_name': 'Research', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012270', 'descriptor_name': 'Ribosomes', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012270', 'descriptor_name': 'Ribosomes', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1081/cnv-120016408', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S121125331', 'display_name': 'Cancer Investigation', 'issn_l': '0735-7907', 'issn': ['0735-7907', '1532-4192'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/12643015', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/17', 'display_name': 'Partnerships for the goals', 'score': 0.54}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 40, 'referenced_works': ['https://openalex.org/W1537425172', 'https://openalex.org/W1564332803', 'https://openalex.org/W1573615374', 'https://openalex.org/W1974313819', 'https://openalex.org/W1980782542', 'https://openalex.org/W1983430641', 'https://openalex.org/W1989177534', 'https://openalex.org/W1994297035', 'https://openalex.org/W1995568086', 'https://openalex.org/W2000719340', 'https://openalex.org/W2004950744', 'https://openalex.org/W2007558322', 'https://openalex.org/W2007720665', 'https://openalex.org/W2009951910', 'https://openalex.org/W2018185888', 'https://openalex.org/W2021861470', 'https://openalex.org/W2024302518', 'https://openalex.org/W2027389053', 'https://openalex.org/W2032206809', 'https://openalex.org/W2032723734', 'https://openalex.org/W2038654603', 'https://openalex.org/W2053503219', 'https://openalex.org/W2054542253', 'https://openalex.org/W2062844537', 'https://openalex.org/W2066129324', 'https://openalex.org/W2082390299', 'https://openalex.org/W2091699055', 'https://openalex.org/W2093811499', 'https://openalex.org/W2120589124', 'https://openalex.org/W2130906103', 'https://openalex.org/W2134534141', 'https://openalex.org/W2143918358', 'https://openalex.org/W2149584883', 'https://openalex.org/W2154200023', 'https://openalex.org/W2157185143', 'https://openalex.org/W2166382251', 'https://openalex.org/W2341689528', 'https://openalex.org/W2409817548', 'https://openalex.org/W2492082888', 'https://openalex.org/W2620176919'], 'related_works': ['https://openalex.org/W4366235067', 'https://openalex.org/W4206379684', 'https://openalex.org/W4205762803', 'https://openalex.org/W3205561628', 'https://openalex.org/W2938078090', 'https://openalex.org/W2292142370', 'https://openalex.org/W2092633871', 'https://openalex.org/W2091596615', 'https://openalex.org/W2045732402', 'https://openalex.org/W1585256759'], 'abstract_inverted_index': {'From': [0], 'may': [1], '99,': [2], 'three': [3, 83], 'european': [4], 'leaders': [5], 'in': [6, 40, 52, 79], 'anti-cancer': [7], 'drug': [8, 54, 60], 'development': [9, 55, 78], '(EORTC,': [10], 'Cancer': [11], 'Research': [12], 'UK,': [13], 'SENDO)': [14], 'have': [15, 33, 45], 'got': [16], 'together': [17], 'to': [18, 36, 62], 'form': [19], 'a': [20, 47], 'network': [21], 'of': [22, 64, 81], 'collaborating': [23], 'groups:': [24], 'the': [25, 73, 82], 'European': [26], 'Drug': [27], 'Development': [28], 'Network.': [29], 'The': [30], 'member': [31], 'organisations': [32, 84], 'all': [34, 57], 'agreed': [35], 'join': [37], 'their': [38], 'efforts': [39], 'developing': [41], 'new': [42], 'drugs.': [43], 'They': [44], 'acquired': [46], 'great': [48], 'and': [49, 67, 88], 'efficient': [50], 'expertise': [51], 'anticancer': [53], 'covering': [56], 'aspects': [58], 'from': [59], 'screening': [61], 'refinement': [63], 'trial': [65], 'methodology': [66], 'translational': [68], 'research.': [69], 'In': [70], 'this': [71], 'paper,': [72], 'most': [74], 'interesting': [75], 'drugs': [76], 'under': [77], 'each': [80], 'are': [85], 'being': [86], 'described': [87], 'discussed.': [89]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2045732402', 'counts_by_year': [{'year': 2023, 'cited_by_count': 1}, {'year': 2020, 'cited_by_count': 1}], 'updated_date': '2024-12-11T19:55:23.443468', 'created_date': '2016-06-24'}